HIMSS and Health 2.0 European Conference Helsinki, Finland 7-9 September 2020
Are you an innovator looking for networking opportunities with the leading players in health tech? Are you a startup or SME looking for funding to develop tomorrow’s digital health solutions? Are you an investor tracking the market to find and support the brightest ideas? At VentureConnect Europe (formerly EC2VC), investors and startups can show-off innovative technologies, connect with reliable business partners, and start to flourish on the digital health market.
According to the latest report by RockHealth, in 2019, digital health companies raised a total of $7.4B across 394 deals from 627 investors. The digital health landscape is healthier than ever: healthcare providers are opening to innovations; new regulations are supporting transformative changes; health insurers (public and private) are starting to reimburse digital health solutions and telemedicine consultations; cooperation between tech companies, research and academia have sped up the development of a new generation of digital solutions; and most of the countries in the EU have developed long-term digital and AI strategies. A new regulatory environment is setting the foundations for a mature market and improved consumer trust. For example, in May 2020, the EU is rolling out the Medical Devices Regulation (MDR), which also includes digital health solutions. Many studies show the positive outcomes of digital health interventions. And there are still so many systemic problems in healthcare that need to be addressed with technology urgently..
Last, but not least: patients demand changes for better, longer lives. The switch towards preventive and predictive care models, affordable and accessible services, and personalized medicine will continuously drive digital health, shaping the healthcare systems globally. As stated in the “2020 global health care outlook” by Deloitte, healthcare spending is expected to rise at CAGR of 5% over 2019-2023. The sector is hungry for innovation to become more sustainable and patient-friendly.
Investors want to make sure that they only have the most promising startups in their portfolio. Similarly, startups search for balanced and stable funding that guarantees long-term development. Both parties are trying to recognize early market opportunities. Will the cooperation in innovation development secure the return on investment and spell market success in the future? Will stakeholders and patients accept a specific idea? Amongst the many factors recognized to bring success to digital health companies, one factor is certainly a must: finding a good fit partnership.
Combining the experience from the former editions of the EC2VC Investors’ Forum and Pitch Competition and the expertise of the HIMSS international community, a new formula for investors and startups has been developed - VentureConnect. This is a networking-oriented event and a marketplace for startups, SMEs, and investors, linking supply and demand in health tech.
VentureConnect continues the success of the previous editions of the EC2VC event. In 2019, two startups won the EC2VC: Thryve and StethoMe. Recently, both have been rolling out dynamically, benefiting from international recognition on the health tech market.
StethoMe (Poland) is a smart, mobile stethoscope for telemedicine applications. It relies on medical AI algorithms to detect abnormalities in the lungs and heart. Wojciech Radomski, CEO & Founder of StethoMe, admits that EC2VC positively affected their business relations and enabled them to reach potential partners more efficiently. “StethoMe got access to the key stakeholders and mass media. We have found potential business partners who perfectly match our target market and requirements,” answered Radomski during an interview in February 2020.
The second winner, Thryve (Germany), is a health data hub integrating all customer's data from smartphones, wearables, and connected medical devices through one plug&play app. It already covers 350+ different devices in more than 33 countries. “Winning the prestigious EC2VC championship ignited visibility at scale for Thryve. It kicked-off our growth and international expansion. We tripled our customer numbers to more than 40, coming from all healthcare verticals, which created a truly global presence. Right now, health services from all over Europe rely on Thryve, from the UK to Poland, from Finland to Israel,” reveals Friedrich Lämmel, CEO & Founder of Thryve. He also emphasizes that being chosen as the leading frontrunner in healthcare generated interest from VCs accross Europe, both directly on site, but also after the event.
The VentureConnect event will take place on May 28th (13:30-16:30), under the agenda of the HIMSS Europe & Health 2.0 Conference in Helsinki.
If you are an investor. With an exclusive focus on digital health, VentureConnect is free to attend. Click here to proceed to a registration form. Your participation in VentureConnect comes with 25% off the admission rate to visit the entire HIMSS & Health 2.0 European Conference & Exhibition 2020. The Early Bird Discount ends 15 March so don’t delay.
If you are a startup. Take your chance to be recognized on a grand stage. Click here to submit your application to the VentureConnect pitch competition before April 10th. On April 24th, ten finalists will be invited to present their solutions in front of a jury of the most influential digital health investors in Europe. Presenters will introduce their solution in a 4-minute pitch, followed by 6 minutes of Q&A. Startups that apply to demo can to apply to VentureConnect.
More details, eligibility and judging criteria, prizes, and information on the application process can be found here.